Evidence map›Paper›PMID 35873593›Full record

ArticleFrontiers in pharmacology2022

Dapagliflozin Protects Methamphetamine-Induced Cardiomyopathy by Alleviating Mitochondrial Damage and Reducing Cardiac Function Decline in a Mouse Model.

Shanqing He, Yajun Yao, Nan Yang, Youcheng Wang, Dishiwen Liu, Zhen Cao, Huiyu Chen, Yuntao Fu, Mei Yang, Songjun Wang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Shanqing HeDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Yajun YaoDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Nan YangSchool of Forensic Medicine, Xinxiang Medical University, Xinxiang, China.
Youcheng WangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Dishiwen LiuDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Zhen CaoDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Huiyu ChenDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Yuntao FuDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Mei YangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Songjun WangHebei Key Laboratory of Forensic Medicine, Hebei Medical University, Shijiazhuang, China.
Guangjie HeSchool of Forensic Medicine, Xinxiang Medical University, Xinxiang, China.
Qingyan ZhaoDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Wuhan University · CNRenmin Hospital of Wuhan University · CNXinxiang Medical University · CNHebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apoptosiscardiomyopathydapagliflozinmethamphetaminemitochondrial

Identifiers

PMID35873593
PMCPMC9301370
OpenAlexW4284683328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.